EC actions against the rising threats
from Antimicrobial Resistance
Workshop on Antimicrobial Resistance
Koen Van Dyck
Head of Unit
SANTE DDG2.G4: Food, Alert system and Training
Directorate General Health & Food Safety (DG SANTE)
European Commission
16-17 November 2015 – Brussels
According to data from 2011, 25 000 patients die annually as a result of infections caused by resistant
bacteria in the EU. The costs incurred by drug resistant infections amount to an estimated €1.5
billion annually, due to increases in healthcare expenditure costs and productivity losses.
http://www.compoundchem.com/2014/09/08/antibiotics/
AMR is a major European and global
societal problem
Decision-makers
Scientific advice
International
organisations
Committees
CHVP
CVMP
ESVAC
Codex
Alimentarius
Networks
EARS-Net
ESAC-Net
Scientific
committees
Regulations; Directives;
EC communications /
decisions; Council
conclusions /
resolutions /
recommendations
SCENIHR
Guidelines,
technical reports,
scientific advice,
recommendations
Guidelines, reports
AMR a public health priority
Some actions taken so far:
Ban on the use of AM for growth promotion (2006)
Monitoring AMR and use of antimicrobials
(EU agencies: EFSA, EMA, ECDC)
International activities (TATFAR, Codex, OIE)
Research
Scientific opinions, data on monitoring
Not enough, further action needed !
5
5
AMR a public
health priority!
COM (2011) 748 – 17 Nov 2011
• 5 year action plan
•
•
•
Holistic approach
7 key areas
12 concrete actions
6
The 12 actions
Human
Veterinary
1. Appropriate
use
8. International
cooperation
2 & 3. Appropriate
use
4. Prevention of
infections
11. Research &
Innovation
5. Prevention of
infections
6. New
antibiotics
12.
Communication,
education
7. Need for new
antibiotics
9. Surveillance
10. Surveillance
7
A. Appropriate use of antimicrobials
Action nº1: Strengthen the promotion of the appropriate use of
antimicrobials in human medicine in all Member States
Action nº2: Strengthen the regulatory framework on veterinary
medicines and on medicated feed
Action nº3: Introduce recommendations for prudent use in
veterinary medicine
B. Prevent microbial infections & spread
Action nº4: Strengthen infection prevention and control in
healthcare settings
Action nº5: Adoption of a proposal for an EU Animal Health Law
C. Develop new effective AM or alternatives for
treatment
Action nº6: Promote unprecedented collaborative research
Action nº7: Promote efforts to analyse need for new antibiotics
into veterinary medicine
D. Join forces with international partners
Action nº8: Develop and / or strengthen multilateral and
bilateral commitments for the prevention and control of AMR
E. Monitoring and surveillance
Action nº9: Strengthen surveillance systems on AMR and
antimicrobial consumption in human medicine
Action nº10: Strengthen surveillance systems on AMR and
antimicrobial consumption in animal medicine
F. Additional Research and Innovation
Action nº11: Reinforce and co-ordinate research efforts.
Innovation.
G. Communication, education and training
Action nº12: Survey and comparative effectiveness research
Next steps
•
Dedicated webpage
http://ec.europa.eu/dgs/health_food-safety/amr/index_en.htm
•
AMR progress report
http://ec.europa.eu/health/antimicrobial_resistance/docs/2015_amr_progre
ss_report_en.pdf
•
AMR Roadmap
•
Ex-post evaluation (February 2016)
http://ec.europa.eu/health/antimicrobial_resistance/docs/roadmap_amr_en.
pdf
Concluding remarks
• AMR remain a top priority for European Commission to lead
at EU and work at global level
• Ongoing evaluation of the EC Action Plan – basis to decide
on the follow-up
• Importance of concrete actions and implementation of the
action plans by all stakeholders and Member States.
Thank you for your attention